Supplemental material, sj-pdf-3-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleukin-1β Inhibitors for Hidradenitis Suppurativa: A Systematic Review by Emmanuel Suntres, Daud Manzar and Raed Alhusayen in Journal of Cutaneous Medicine and Surgery</p
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different countrie...
ABSTRACT Hidradenitis suppurativa (HS) is a chronic debilitating inflammatory skin disease character...
Background: The pathogenesis of hidradenitis suppurativa (HS) is not fully understood. This systemat...
Supplemental material, sj-xlsx-4-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleuki...
Supplemental material, sj-docx-2-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleuki...
Supplemental material, sj-docx-1-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleuki...
Supplemental material, Online supplementary file 1, for Treatment Outcomes of IL-17 Inhibitors in Hi...
Supplemental material, Figure S1, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhi...
Supplemental material, Table S1, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhib...
Supplemental material, Table S3, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhib...
Supplemental material, Table S2, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhib...
Shi Yu Derek Lim,1 Hazel H Oon21Internal Medicine Residency, National Healthcare Group, Singapore, S...
Supplementary files and tables for: "Combined Biologic-and-Surgical Interventions for Hidradeni...
Supplemental material, CMS823529_SM for Combination Therapies for Hidradenitis Suppurativa: A Retros...
This systematic review identifies and critically evaluates the mechanistic and clinical evidence of ...
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different countrie...
ABSTRACT Hidradenitis suppurativa (HS) is a chronic debilitating inflammatory skin disease character...
Background: The pathogenesis of hidradenitis suppurativa (HS) is not fully understood. This systemat...
Supplemental material, sj-xlsx-4-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleuki...
Supplemental material, sj-docx-2-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleuki...
Supplemental material, sj-docx-1-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleuki...
Supplemental material, Online supplementary file 1, for Treatment Outcomes of IL-17 Inhibitors in Hi...
Supplemental material, Figure S1, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhi...
Supplemental material, Table S1, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhib...
Supplemental material, Table S3, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhib...
Supplemental material, Table S2, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhib...
Shi Yu Derek Lim,1 Hazel H Oon21Internal Medicine Residency, National Healthcare Group, Singapore, S...
Supplementary files and tables for: "Combined Biologic-and-Surgical Interventions for Hidradeni...
Supplemental material, CMS823529_SM for Combination Therapies for Hidradenitis Suppurativa: A Retros...
This systematic review identifies and critically evaluates the mechanistic and clinical evidence of ...
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different countrie...
ABSTRACT Hidradenitis suppurativa (HS) is a chronic debilitating inflammatory skin disease character...
Background: The pathogenesis of hidradenitis suppurativa (HS) is not fully understood. This systemat...